{{Cite journal| doi = 10.1016/j.rpth.2024.102534| issn = 2475-0379 (Electronic) 2475-0379 (Linking)| volume = 8| issue = 5| pages = 102534| last1 = Fumagalli| first1 = R. M.| last2 = Voci| first2 = D.| last3 = Bikdeli| first3 = B.| last4 = Bingisser| first4 = R.| last5 = Colucci| first5 = G.| last6 = Forgo| first6 = G.| last7 = Gerardi| first7 = T.| last8 = Gerber| first8 = B.| last9 = Grigorean| first9 = A.| last10 = Klok| first10 = F. A.| last11 = Righini| first11 = M.| last12 = Robert-Ebadi| first12 = H.| last13 = Stortecky| first13 = S.| last14 = Ulrich| first14 = S.| last15 = Wolf| first15 = S.| last16 = Wyss| first16 = D.| last17 = Hobohm| first17 = L.| last18 = Kucher| first18 = N.| last19 = Barco| first19 = S.| last20 = investigators| first20 = Ovid| title = Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial| journal = Res Pract Thromb Haemost| date = 2024-09-10| pmid = 39252826}}